|
Welcome to Dicks
Guides #2 with
Dick's Cyberspace Mall, the World's Largest Internet Mall with over 1000 shops.
Free
information provided by Dick's Cyberspace Mall, the
WORLD'S LARGEST MALL
You're visitor number
|
|
Dick's Guide to Fibrositis or Fibromyalgia (or FMS)
It has been estimated that up to 6 million United States citizens have been diagnosed with fibromyalgia syndrome. Researchers know little about its cause, symptoms, or effective treatment. It is hard to know if people diagnosed with this syndrome really have it, and it's equally clear that symptomatic patients may not have been correctly diagnosed. According to the Nurse Practitioner, "FMS may be one of the most common disorders family health care providers encounter in ambulatory practice; however, it is one of the most underreported." FMS patients may be told by providers that there is nothing wrong with them. As FMS causes and symptoms are more clearly understood, more patients are likely to be diagnosed. It's reported that, "The average patient with FMS has had the disease for 5 years and has spent thousands of dollars on medical tests before he or she receives the diagnosis. In addition, more than half of FMS patients undergo unnecessary surgery due to misdiagnosis." Symptoms reported by FMS patients: persistent pain in the neck, shoulder, low back, and hip; waking up without feeling rested; severe fatigue; waking frequently during the night; waking with stiffness and achiness; hypersensitivity to cold and/or heat; complaints of abdominal pain; recurrent fronto-occipital headaches; sensations of numbness or tingling in hands and feet; constipation and diarrhea; and anxiety and depression.[1,5] Other symptoms spastic colon, mitral valve prolapse, bursitis, chondromalacia, temporomandibular joint dysfunction, vertigo, sinus and thyroid problems, concentration problems, swollen glands, and tinnitus. dyspnea, hypoglycemic- like syndrome, dysphagia, vasomotor rhinitis, mold and yeast sensitivity, menstrual problems, memory impairment, motor coordination problems, pseudoangina, conjunctivitis, carbohydrate craving, sensitivity to cold, bloating, bruising, tender lymph nodes, sore throat, leg cramps, groin pain, mottled skin, muscle twitching, and lack of endurance. FMS is a widespread musculoskeletal pain and fatigue disorder with an unknown etiology. It is unlikely that the majority of patients with FMS are accurately diagnosed, and few receive any education about the condition. After diagnosis, it is often difficult to locate a practitioner who will work with the patient to determine the best way to control the symptoms. This often requires patients to work out and search for remedies on their own. Due to the chronic nature of FMS, relationships among family members, friends, and coworkers can be affected. Because FMS does not involve outwardly visible signs and symptoms, educating family, friends, and coworkers is crucial to ensure that the FMS patient receives the support he or she needs. Diagnosis In 1990, the Copenhagen Declaration established FMS as a diagnosis. The diagnosis was incorporated into the International Statistical Classification of Diseases and Related Health Problems that went into effect on January 1, 1993. The new document defines FMS as a painful, nonarticular condition predominantly involving muscles and the most common cause of chronic, widespread musculoskeletal pain. Onset of symptoms usually occurs between the ages of 20 and 40 years, predominantly in women. Tender points are the most powerful discriminator between FMS and controls.[10] They occur in anatomically precise locations and have been shown to have construct validity when correlated with fibrornyalgia symptoms. The diagnosis is based mainly on objective testing for the presence of tender points. The tender points occur in muscles or the area where a muscle joins a tendon.[11] Diagnostic criteria were defined by the American College of Rheumatology (ACR) in 1990.[10] The ACR concluded that FMS could be diagnosed by a history of widespread pain in at least 11 out of 18 specified tender points in muscular tissue. Pain was described as widespread if it was felt in all of the following regions: left and right sides of the body, above and below the waist, and in the axial skeleton (cervical spine, anterior chest, thoracic spine, or low back).[10] The 18 tender point sites on digital palpation identified by the ACR are shown in Figure 1. To meet ACR diagnostic criteria for FMS, digital palpation with an approximate force of 4 kilograms of pressure must produce a report of pain in at least 11 of these 18 tender points. Bilateral palpation with moderate pressure of 11 thumbs (examiner's thumbnail should blanch)[12] should produce pain in the tender point areas. Unaffected patients may also be slightly tender at these points, but fibrornyalgia patients will exhibit a reduced pain tolerance symmetrically at the tender points.[10,12,13] The tenderness should be localized to the tender points rather than diffuse aching. Tender points must be present on both sides of the body, above and below the waist, and in the midline. Pain in the tender point areas must have been present for at least 3 months. Some clinicians accept a diagnosis of fibrornyalgia with fewer than 11 tender points, if several associated symptoms are present.[10] The Copenhagen Declaration divided ACR's definition into a pragmatic and clinical perspective: "The diagnosis is commonly entertained in the presence of unexplained widespread pain or aching, persistent fatigue, generalized (morning) stiffness, nonrefreshing sleep, and multiple tender points. A variable proportion of otherwise typical patients may have less than 11 tender points at the time of the examination." The document continues to state that FMS is often "part of a wider syndrome encompassing headaches, irritable bowel, dysmenorrhea, cold sensitivity, Raynaud's phenomenon, restless legs, atypical patterns of numbness and tingling, exercise intolerance and complaints of weakness." [9] The Copenhagen Declaration emphasized the fact that patients with FMS should not be considered hypochondriacs. Although the etiology of FMS is unknown, members of the consensus panel ruled out psychologic distress as a cause of the muscular pain and tenderness. In fact, the document states, it could be the other way around. The psychologic state may be a result of the patient attempting to cope with the pain.[9] Although the terms tender points and trigger points have been used interchangeably, they are now considered separate entities and are associated with different syndromes.[14] Tender points are localized areas of exaggerated tenderness at anatomically reproducible sites. A trigger point, when palpated, produces pain referred to a distant site, such as when pressure applied to the neck produces pain down the arm. Trigger points are associated with syndromes of localized myofascial pain, and in some cases, possible nerve root compression. The pain may or may not be related to the tender points of FMS.[15] Tender points became the cardinal feature of FMS after Smythe and Moldofsky published their article in 1977.[16] They proposed criteria of chronic aching, a nonrestorative sleep pattern with marked morning stiffness and fatigue, an electroencephalographic (EEG) finding of alpha intrusion in non-rapid eye movement (non-REM) sleep, localized tenderness at 12 of 14 specific sites, and marked skin-fold tenderness in the upper scapular region. They introduced the symptom complex identified with FMS today that led to several quantitative and controlled trials. Historical Perspectives The concept of FMS has evolved, and in the minds of many, differs from the view of the disorder 30 to 50 years ago.[10] These changes, in part, are the result of diagnostic criteria that defined the syndrome. Thus, the emphasis on irritable bowel syndrome and modulating factors added a dimension to FMS. Some investigators have suggested that FMS is a psychologic disorder, or perhaps a myofascial pain syndrome. This disarray in construct has led to confusion regarding the nature of the disorder and to the consequent idea that FMS means something different to every observer. The first controlled study on FMS was published in 1981.[17] Previous to this study, the condition was described as having pain, fatigue, and tender points. The study identified many more symptoms besides pain that patients with FMS had in common. Documentation concluded that fibromyalgia is actually a syndrome. [18] Many researchers were quick to criticize the study. They stated that one could not demonstrate FMS objectively, or show any neurologic damage or swelling. They professed that the symptoms were really manifestations of depression or the stress of society. A study in 1982 may have contributed to the early emphasis on psychologic factors.[19] Thirty hospitalized primary fibromyalgia syndrome patients (PFS) were compared with 30 rheumatoid arthritis (RA) patients using the Minnesota Multiphasic Personality Inventory (MMPI). The results revealed significantly elevated scores in the PFS group in several areas. Based on the results, researchers concluded that PFS patients are psychologically disturbed. Further studies have refuted those findings. Stringent analysis with various psychologic models has found no correlation between any of the symptoms and the mental status of patients. A subsequent study extended the work of the earlier study, but the design differed in that ambulatory PFS patients were studied and a normal comparison group was included in addition to the RA group.[20] Additionally, researchers sought to examine the presence of subpopulations of PFS patients based upon responses to the MMPI, as well as to assess the association of stressful life events and social skills in PFS. Their results found fewer differences between the PFS and RA patients. Two potential explanations can be offered for the differences from the earlier study: (1) ambulatory patients, in general, display a lower level of psychologic disturbance than hospitalized patients; and (2) the inclusion of the normal comparison group revealed that some of the differences between PFS and RA patients found in the early study may be explainable by a depression of the RA scale means rather than an elevation of PFS means (i.e., the RA patients' means may be lower than a healthy population and the PFS means may be similar to a healthy population). In a second study by the same researcher, the instrument used was the Psychiatric Diagnostic Interview.[21] It was concluded that the instrument failed to discriminate any major differences between PFS (a disorder with no known organic cause) and RA (a disorder with a known organic cause); therefore, a psychopathologic explanation could not be considered as a primary cause of the symptoms of PFS. Subsequent studies found the psychologic aspects of patients with FMS were similar to those with chronic pain.[22] Three groups (chronic pain, nonchronic pain, and FMS) were compared using a stand ardized interview and two psychologic questionnaires. Researchers concluded that the chronic pain group and nonchronic pain group could be easily distinguished from each other. The scores of the FMS group and the chronic pain group were very similar. This led to the conclusion that many psychologic aspects of FMS can be considered as psychologic aspects of chronic pain. An additional study had similar findings.[23] Researchers hypothesiezed that there is a correlation between the sites of pain and the sites of symptoms. Their report confirmed that the pain and symptoms are centrally modulated and not determined by psychologic status. Etiology/Pathogenesis The etiology and pathogenesis of FMS are unknown. A variety of mechanisms have been postulated. Researchers have focused on the fibrositic tender point, possible electromyographic response, and tissue histology and chemistry. Light microscopic abnormalities in tissues obtained under tender point muscle biologies are not specifically different, but occur in greater numbers in FMS patients than in normal controls. However, differences in immunoglobulin, cytokine, tissue metabolism, capillary permeability, as well as increases in central nervous system substance P levels and tissue changes analogous with experimental interleukin-2 infusion, were significant enough to suggest a definite abnormality in the immunologic system.[24] Using light microscopes, researchers could not find any evidence of an inflammatory process in either tendon or muscle tissues.[25] However, with an electron microscope, they detected severe damage and even dissolution of myofilaments. They propose that in FMS there are two totally different tissues affected: (1) the bradytrophic collagenous connective tissue that requires little oxygen and (2) the highly active skeletal muscles, made up of muscle cells that require a high amount of oxygen. The way these two tissues react to disorders is also different. The collagenous tendon and capsular tissues react to lack of oxygen and overstrain by excessive formation of fibroblasts and dissolution of collagen fibers. Muscle tissue reacts to nerve irritations by pathologic muscle changes in extensive areas in the body.[25] A consistent loss of stage 3 to 4 non-REM sleep has been observed in patients with fibromyalgia and with other diseases associated with aching and stiffness. Normal individuals deprived of stage 4 sleep develop a fibromyalgia like syndrome.[15] Several hypotheses have been identified, including sleep disturbance, infectious agent(s), stress, and trauma from accidents or surgery. Metabolic factors including neurotransmitters, hormones, enzymes, immune system chemicals, energy compounds, products produced by the body's cells, and the breakdown products of foods have been identified as possible etiologic factors of FMS.[26] Nonrestorative sleep has a well -established association with FMS, but the role it plays in the pathophysiology of the syndrome has not been clarified. The sleep disorder most frequently identified with FMS patients is the stage-4 sleep anomaly.[27] Growth hormone secretions may be disrupted by the poor quality of sleep seen in FMS patients. Growth hormone is released almost exclusively in stage-4 sleep. It has been theorized that FMS is a disorder of nonrestorative sleep with a specific neurochernical abnormality common to pain, sleep disturbance, and depression.[28] They suggest an abnormality in serotonin metabolism. Serotonin is important in deep sleep and in central and peripheral pain mechanisms. Amitriptyline, the most commonly used medication for treating FMS, blocks serotonin reuptake and increases deep sleep.[29] Other studies have suggested the possible involvement of substance P and catecholamines.[30] In one additional study, patients with FMS were shown to have a neurotransmitter profile similar to those in other chronic pain states.[31] The sleep problem associated with FMS varies from sleep fragmentation to alpha-wave intrusion into deep level sleep (awake-like brain waves interfering with deep sleep).[32] Two different hypotheses on the function of sleep are relevant to FMS: (1) sleep is necessary for tissue restoration or bodily renewal, and (2) sleep is necessary for regulating many neuroendocrine and immune functions.[32] An infectious cause of FMS has been hypothesized based upon the observed similarity of this entity and chronic fatigue syndrome. A careful search for viral infections in FMS patients whose symptoms appear following a "flu-like" illness is warranted.[33] An infectious disease component may be responsible for FMS.[34] Suspected agents have included Epstein-Barr, cytomegalovirus, human herpesvirus 6, enteroviruses, B. burgdorferi, and HIV. Some of these agents have been ruled out as actual causative agents, but it is thought that "the manipulative nature of these infectious agents might lead susceptible people into an altered immune system state of reduced natural killer cell function and increased interferon activity."[34] It is suspected that the pain and other symptoms of FMS are transmitted through the central nervous system by many chemicals called neurotransmitters. Substance P is known to play a role in pain transmission while serotonin, norepinephrine, dopamine, and other chemical transmitters work in an inhibitory fashion to reduce or modulate the effects of pain signals coming from the central nervous system.[18] There have been suggestions that psychogenic factors may contribute to FMS, but research has not supported the hypothesis.[15] The literature revealed that there were not any psychologic abnormalities or certain personality types found in patients with FMS. This was important in ruling out a psychologic etiology for FMS. Since the etiology is unknown and there are not easily demonstrative objective abnormalities, FMS becomes a prime target for psychologic or somatiform etiologies.[35] Study results argue against such a mechanism playing a role in the perpetuation of FMS. A number of other findings, including the response of pain to weather fronts, the marked stiffness comparable to other rheumatic diseases, the consistent location of the fibrositic tender points, the occasional finding of palpable nodules with electromyographic and histologic abnormalities, and the disturbance of sleep all suggest a peripheral or, at least, nonpsychogenic component of the syndrome. Despite this, there is a common clinical impression that a number of these patients are psychologically abnormal. Longstanding or severe pain and disability may result in the development of emotional abnormalities like those seen in patients with RA and other chronic diseases.[35] Researchers continue to study FMS patients to determine the etiology of the illness and to validate or disprove the many theories postulated about the cause of FMS. Treatment Recommendations Treatment for fibrornyalgia necessitates a multifaceted approach to control symptoms in several areas. Interventions to aid sleep, relieve pain, and control headaches and gastrointestinal disturbances, as well as gentle exercise to aid in muscle conditioning are all utilized to treat the FMS patient. Since FMS patients differ greatly in their symptoms and their severity, it is critical to tailor a treatment regimen to each individual patient. Medications The medication needs of patients with FMS must be addressed. Health care providers and patients with FMS should be educated on the latest research on effective medications and treatments. There is a great deal of difficulty and confusion in identifying the best way to medically manage the FMS patient. Patients and their health care providers must work together closely, on a one-on-one basis, to identify the medications and treatment that are appropriate. Medications such as tricyclic antidepressants have been utilized as therapeutic agents since Moldofsky described an alpha-delta sleep disturbance in 1975. In the FMS patient, antidepressants work to increase non-REM stage 4 sleep by increasing serotonin levels, rather than in an anti-depressive manner. Amitriptyline is the most commonly used medication to treat FMS. Controlled studies by several researchers have shown significant improvement following use of amitriptyline.[36- 39] Other tricyclic antidepressants shown to be effective in controlled studies are cyclobenzaprine (Flexeril),[40-42] and imipramine (Tofranil).[43] Trazodone (Desyrel) was effective in increasing slow wave sleep, normalizing REM latency, and reducing the alpha-delta pattern.[44] Serotonin reuptake inhibitors like fluoxetine (Prozac) are also beneficial. Fluoxetine (Prozac) can be stimulating and contribute to sleep disturbances, so a combination of a bedtime tricyclic and a morning medication like fluoxetine (Prozac) may work better for the patient fighting fatigue. A randomized, double-blinded, crossover study compared fluoxetine (Prozac) alone, amitriptyline alone, and a combination of amitriptyline and fluoxetine (Prozac). The combination therapy significantly reduced pain, improved sleep, and increased patient functionality and sense of overall well-being. Individual effects of amitriptyline and fluoxetine (Prozac) were comparable, but not as good as the combination.[45] Venlafaxine (Effexor) and bupropion (Wellbutrin)[46] can be tried as well, although more clinical studies are needed to substantiate the favorable effect for FMS patients. Zolpidem (Ambien) has been found to be helpful in treating sleep difficulties and improving daytime energy in FMS patients, although it did not alter pain levels.[47] The drug is marketed as a short- term insomnia aid and should be limited to two to three nights per week.[48] Alprazolam (Xanax) can also be used as a sleeping aid. Alprazolam (Xanax) was shown to be significantly beneficial in a study by Russell.[49] Muscle relaxants can be used to treat muscle spasms and to control pain. Cyclobenzaprine (Flexeril) is an antidepressant with muscle relaxant qualities.[40-42] Tramadol (Ultram) and topical anesthetics are effective in some patients in the treatment of pain, although controlled trials are needed to substantiate the claim.[50] Clinicians must be willing to adjust dosages and try different medications in different combinations to identify the most effective medications for each patient.[45] Interdisciplinary Approach Several researchers have found that an interdisciplinary approach to the treatment of FMS is beneficial to the FMS patient.[51-54] One study involved a group of 36 patients who completed a 6-month program including education, support groups, stress reduction, cognitive restructuring, antidepressants, trigger point therapy, and aerobic conditioning. Improvements were noted in the areas of functional impairment, quality of life, pain analog scores, number of tender points, total myalgic score, attitudes index, pain behavior, and Beck depression and anxiety. The study was not blinded; however, the improvements seen over the 6-month trial were much greater than the placebo response reported in previous studies.[51] Another study demonstrated improvements in social function, fatigue, and vitality in a study of 35 patients with a diagnosis of FMS and/or chronic fatigue syndrome who participated in a treatment regimen that included education, counseling, development of self-management techniques, and acupuncture.[53] Patients were followed for 6 months after a treatment program including education, aerobic exercise, stretching exercise, pain control, stress management, pacing, and body mechanics. Significant improvements were seen in pain severity, life control, affective distress, perceived support, and perceived interference.[54] Exercise Exercise is the primary nonpharmacologic treatment of FMS. Research studies have confirmed the benefits of exercise in the FMS patient.[55- 57] A randomized, controlled study of 42 patients who participated in a 20-week program of either cardiovascular fitness training or simple flexibility exercises determined modest improvements in both objective and subjective pain measurements.[55] Significant improvements in cardiovascular fitness, pain threshold scores of tender points, and both patient and physician global assessment scores were demonstrated. In addition, there was a trend toward decreased intensity of pain in the cardiovascular group. Other studies demonstrated positive benefits from exercise. Forty- one patients demonstrated improvements in walk distance, well-being, and fatigue following a 6-week program of aquafit classes and group education.[56] An additional study of 36 patients who participated in a 6-month program that included aerobic conditioning and flexibility exercises showed that FMS patients can be motivated to exercise, that exercise does not cause an increase in pain when appropriate levels are followed, and enhanced flexibility and endurance are dependent upon exercising at the prescribed level.[57] Self-management Patients with FMS would also benefit from education on effective self- care treatment options (see Patient Education). They should be taught techniques that they can use at home to decrease pain, muscle spasm, and tightness and improve sleep.[11] Patients and their family members should be educated in these treatment techniques, with self-management being the ultimate goal. Self-treatment strategies should include heat therapy, stretching techniques, massage, relaxation techniques, and the benefits of walking for exercise. Heat therapy should include information regarding the use of moist hot packs, heating pads, whirlpool baths, and warm baths or showers.[12] Flexibility stretching techniques should emphasize the involved body areas and the need to stretch slowly, gently, and gradually, starting out with several repetitions and then working to increase tolerance.[58] Massage should be taught for its relaxation and physiologic benefits. When learning massage, the patient would benefit from self- massage techniques and instruction to his or her significant other about how to properly massage the patient with FMS. The benefits of both massage and transcutaneous electrical nerve stimulation were tested in a group of 30 FMS patients and found to be beneficial.[59] Relaxation techniques should include such activities as deep breathing, visualization, biofeedback, meditation, autogenic training, and progressive relaxation.[60] Walking should be emphasized for its importance to maintain heart and lung conditioning and to help increase circulation and maintain muscle strength. Demanding exercise should be avoided, with walking beginning in a gradual fashion and increasing as tolerated.[11, 58] Other therapies found to be beneficial for some patients include acupuncture,[61] acupressure,[58] spray-and-stretch techniques,[58, 62] and stress reduction.[60] Patients with FMS should be made aware of methods to manage their sleep disorder and cope with their fatigue.[62] If patients with FMS are able to manage their sleep disturbance, they may be able to have better control over fatigue and pain levels. Conclusion Prompt diagnosis of the patient exhibiting symptoms of FMS will prevent years of unnecessary suffering. Effective treatments are available to increase the quality of life of FMS patients and their families. Together, the health care provider and patient can plan a beneficial, multifaceted treatment regimen. Source: Maurizio, Sandra J.; Rogers, Janet L., Recognizing and treating fibromyalgia. (Continuing Education, with test)., Vol. 22, The Nurse Practitioner, 12-01-1997, pp 18(12). Website for:
More Information
Click below if you need
return to Welcome to Dick's Guides or Dick's Guide's Free Service for Research Reports and Questions or Dick's Guide Resource Library or Money Making Opportunities for Students or How Older American Politicians, Lawyers and Bureaucrats Screw Young People, all the time
Dick's Guide to Free URL Registration Sites (I have used these sites to get free registration for Dick's Guides on various Search Engines. They work and they are free! Use them to spread the word about your Web Page.) Search Engines I have known and loved
THE LEGAL JARGON I SEEM TO NEED ON MY PAGES "Netscape, Netscape Navigator, Netscape ONE and the Netscape N and Ship's Wheel logos are registered trademarks of Netscape Communications Corporation in the United States and other countries. are also trademarks of Netscape Communications Corporation, which may be registered in other countries."
So be it |
|